NCT01106274已完成不适用

Study of the Effects of Riboflavin/ Ultraviolet-A Corneal Cross-linking

Mashhad University of Medical Sciences0 个研究点目标入组 20 人开始时间: 2008年11月1日最近更新: 2010年4月19日

研究概览

简要总结

Recently, riboflavin (0.1%) and ultraviolet-A (UVA) collagen cross-linking (C3R) has shown potential to improve the signs and symptoms of bullous keratopathy .The objective of this study is to demonstrate the effects of C3R to treat bullous keratopathy.

研究设计

研究类型: Interventional
分配方式: Na
干预模型: Single Group
主要目的: Treatment
盲法: None

入排标准

年龄范围: 20 Years 至 80 Years（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•patients with bollous keratopathy

排除标准

•corneal scarring or contemporary eye disease affecting VA were excluded.

研究者

发起方

Mashhad University of Medical Sciences

申办方类型

Other

相似试验

尚未招募

不适用

Collagen cross linking with riboflavin and ultraviolet A for the treatment of conical ectasia (progression) in keratoconic corneas: Analysis of clinical outcomes and micro structural changes.Keratoconus

ACTRN12608000367347niversity of Auckland50

已完成

不适用

Evaluating the effect of UV-A/Riboflavin Collagen Cross-Linking in treatment of bacterial corneal ulcerCorneal ulcerCorneal ulcers.

IRCT2014101919581N1Shiraz Univercity of Medical Seiences

已完成

1 期

Use of Cross-linked Donor Corneas as Carriers for the Boston KeratoprosthesisChemical InjuriesUnspecified Complication of Corneal TransplantAutoimmune DiseasesOcular Cicatricial PemphigoidStevens Johnson SyndromeLupus Erythematosus, SystemicOther Autoimmune DiseasesRheumatoid Arthritis

NCT01582880Joseph B. Ciolino, MD1

已完成

不适用

Combined CXL//UV and PRK or LASIK in Forme Fruste Keratoconus or Eyes With Potential Risk of EctasiaFruste KeratoconusRisk of Ectasia

NCT01726283Cxlusa22

已完成

不适用

Ultraviolet-A and Riboflavin Treatment for Infectious KeratitisInfectious Keratitis

NCT01739673Cxlusa13